EPO Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Recombinant erythropoietin (EPO) is currently indicated for use only in anemia associated with renal transplant or end-stage renal disease. Widened indications for use in other forms of anemia, accompanied by price reductions as a result of keen competition, have been projected for EPO in the future.

Originator

Amgen (USA)

Trademarks

Eprex

EPO Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

EPO Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10356	58
Shanghai Universal Biotech Co.,Ltd	13774214275	zhouzz@univ-bio.com	China	25002	58
Shanghai Yingxin Laboratory Equipment Co., Ltd.	021-021-59178156 17002132182	3146474380@qq.com	China	11603	58
Cayman Chemical Company	800-364-9897	sales@caymanchem.com	China	27736	58
Enzo Biochem Inc	Enzo Biochem Inc. 13797054060	Enzoname@qq.com	China	177174	58

()Verwandte Suche:

---

• EOSINOPHIL PEROXIDASE, HUMAN
• ERYTHROPOIETIN MOUSE
• EPO, HUMAN
• EPO, MOUSE
• MOUSE ERYTHROPOIETIN
• HUMAN ERYTHROPOIETIN
• HUMAN EPO
• EPO
• ERYTHROPOIETIN-ALPHA, HUMAN
• ERYTHROPOIETIN HUMAN
• ERYTHROPOIETIN HUMAN, RECOMBINANT
• EPER
• Hematopoietic Cytokines
• Cytokines and Growth Factors
• Cytokines, Growth Factors and Hormones
• Cell Biology
• Cell Signaling and Neuroscience
• BioChemical